BioCentury
ARTICLE | Clinical News

Buprenorphine/naloxone: Phase III started

August 19, 2013 7:00 AM UTC

Orexo began the double-blind, U.S. Phase III ISTART trial to compare Zubsolv vs. Suboxone buprenorphine/naloxone sublingual film in about 708 patients. Zubsolv is approved in the U.S. for maintenance...